Follow-up of patients diagnosed with polycythemia vera patients with oral symptoms secondary myelofibrosis Lo may imatinib 10 months to observe the blood, spleen size, MPN100 changes in scores and adverse reactions.
One patient with myelofibrosis secondary to polycythemia vera was followed up for 10 months. The changes of blood routine, spleen size, mpn100 score and adverse reactions were observed.